NCT02451150View on ClinicalTrials.gov

A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Pediatric Hypertension
Interventions
DRUG

Azilsartan

Azilsartan tablets

Trial Locations (3)

Unknown

Fuchū

Oofu

Setagaya-ku

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY